These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36810090)

  • 1. Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
    Liu Z; Zhang T; Lin L; Long F; Guo H; Han L
    Biomed Eng Online; 2023 Feb; 22(1):17. PubMed ID: 36810090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of multi-center
    Zuo Y; Liu L; Chang C; Yan H; Wang L; Sun D; Ruan M; Lei B; Xia X; Xie W; Song S; Huang G
    Med Phys; 2024 Jul; 51(7):4872-4887. PubMed ID: 38285641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of
    Li S; Li Y; Zhao M; Wang P; Xin J
    Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
    Zhao HY; Su YX; Zhang LH; Fu P
    Neoplasma; 2022 Jan; 69(1):233-241. PubMed ID: 34779641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Presurgical
    Dai M; Wang N; Zhao X; Zhang J; Zhang Z; Zhang J; Wang J; Hu Y; Liu Y; Zhao X; Chen X
    Cancer Biother Radiopharm; 2024 Oct; 39(8):600-610. PubMed ID: 36342812
    [No Abstract]   [Full Text] [Related]  

  • 9. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
    Chen YH; Wang TF; Chu SC; Lin CB; Wang LY; Lue KH; Liu SH; Chan SC
    PLoS One; 2020; 15(12):e0244502. PubMed ID: 33370365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
    Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
    Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancer.
    Zhang R; Hohenforst-Schmidt W; Steppert C; Sziklavari Z; Schmidkonz C; Atzinger A; Kuwert T; Klink T; Sterlacci W; Hartmann A; Vieth M; Förster S
    Nuklearmedizin; 2022 Oct; 61(5):385-393. PubMed ID: 35768005
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM
    Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
    Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300
    [No Abstract]   [Full Text] [Related]  

  • 17. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of intratumor metabolic and heterogeneity parameters on [
    Ni M; Wang S; Liu X; Shi Q; Zhu X; Zhang Y; Xie Q; Lv W
    Jpn J Radiol; 2023 Feb; 41(2):209-218. PubMed ID: 36219311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
    Mei D; Luo Y; Wang Y; Gong J
    Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
    Zhao M; Kluge K; Papp L; Grahovac M; Yang S; Jiang C; Krajnc D; Spielvogel CP; Ecsedi B; Haug A; Wang S; Hacker M; Zhang W; Li X
    Eur Radiol; 2022 Oct; 32(10):7056-7067. PubMed ID: 35896836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.